(330) 876-1228
8507 Main StreetKinsman, OH 44428
(330) 876-1229
01 Aug
Researchers analyzed cancer incidence and mortality rates across generations and found a significant increase in many types of cancer among Generation X and millennials.
A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer.
Researchers at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., developed the new regimen, a combination of pazopanib (
Opdivo, one of the new generation of immunotherapy cancer treatments, appears to help kidney cancer patients equally well when given as a quick injection versus the current method of intravenous delivery, a new study finds.
The results of the new trial using injected Opd...
Dropping a load of pounds through weight-loss surgery can significantly decrease your risk of developing or dying from cancer, according to three new studies.
Obese folks who underwent bariatric surgery were at least two times less likely to develop certain types of canc...
The use of immunotherapy and/or targeted drugs revolutionized the treatment of many cancers, but some people grow resistant to immunotherapy drugs and relapse as a result.
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.
The study, of more than 700 cancer facilities nationwide, found that i...
People with cancer may be at increased risk for a rare neurological disorder called Guillain-Barré syndrome, new research has found.
"Previous studies have suggested there may be a link between cancer and Guillain-Barré syndrome, but just how often people develop <...
Gender differences extend to cancer treatments, with women having a higher risk of severe side effects from certain treatments than men, a new study finds.
Previous research concluded women tend to have more side effects from chemotherapy, and this new paper shows the sa...
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...